Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$26.28
-5.5%
$29.24
$26.08
$43.18
$1.33B1.28715,394 shs955,655 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$61.27
-1.7%
$69.44
$59.74
$100.19
$3.66B0.58791,532 shs469,954 shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-0.75%-1.10%-3.77%-25.09%-8.28%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+1.14%-8.58%-7.52%-24.45%-33.83%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$26.28
-5.5%
$29.24
$26.08
$43.18
$1.33B1.28715,394 shs955,655 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$61.27
-1.7%
$69.44
$59.74
$100.19
$3.66B0.58791,532 shs469,954 shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-0.75%-1.10%-3.77%-25.09%-8.28%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+1.14%-8.58%-7.52%-24.45%-33.83%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
2.82
Moderate Buy$48.7185.37% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.73
Moderate Buy$92.8051.46% Upside

Current Analyst Ratings Breakdown

Latest ATRC and MMSI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Boost Price TargetBuy$53.00 ➝ $55.00
5/6/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
UpgradeHoldStrong-Buy
5/4/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
DowngradeSell (D-)Sell (E+)
5/1/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Set Price Target$83.00
5/1/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Lower Price TargetBuy$90.00 ➝ $85.00
5/1/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Lower Price TargetOverweight$95.00 ➝ $77.00
5/1/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Lower Price TargetEqual Weight$78.00 ➝ $74.00
5/1/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Lower Price TargetBuy$101.00 ➝ $90.00
4/20/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Reiterated RatingSell (D-)
4/20/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Set Price Target$107.00
4/20/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Reiterated RatingOutperform
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$534.53M2.49$0.29 per share89.49$9.89 per share2.66
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.54B2.37$5.85 per share10.48$27.27 per share2.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$11.45M-$0.10N/A75.09N/A-0.83%0.29%0.22%N/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$128.49M$2.3126.5215.511.929.03%13.54%7.94%N/A

Latest ATRC and MMSI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.07$0.0022+$0.0722N/A$139.75 million$141.25 million
4/30/2026Q1 2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.84$0.94+$0.10$0.68$377.59 million$381.88 million
2/24/2026Q4 2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.96$1.04+$0.08$0.63$390.77 million$393.94 million
2/17/2026Q4 2025
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.04$0.06+$0.10$0.04$140.50 million$140.50 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.13
3.96
2.99
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.45
5.08
3.46

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
4.00%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,30050.63 million48.61 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
7,50059.66 million59.24 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AtriCure stock logo

AtriCure NASDAQ:ATRC

$26.28 -1.52 (-5.47%)
Closing price 04:00 PM Eastern
Extended Trading
$26.29 +0.01 (+0.04%)
As of 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$61.27 -1.06 (-1.70%)
Closing price 04:00 PM Eastern
Extended Trading
$61.22 -0.05 (-0.09%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.